glp-1 weight loss drugs news today A new study is raising concerns about and eating disorders. Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least Weight loss drugs and addiction:

The compound is designated as a research chemical and is not approved for human therapeutic use by any regulatory agency

I was in a better mood

Recommended Dosing Protocols Common bodybuilding and recovery-focused protocols include: Subcutaneous: 200500 mcg once or twice daily, near the injury site or in abdominal fat Intramuscular: 200300 mcg directly into the affected muscle, rotating sites Oral: 250500 mcg dissolved in water once daily, though bioavailability may vary Many protocols begin at the lower end, around 200 mcg, during the first week to assess tolerance

The honest summary: this isn't a compound with five large randomized controlled trials behind it